KMB Kimberly-Clark Corp
Kimberly-Clark Corp. engages in the manufacture and marketing of products made from natural or synthetic fibers. It operates through the following segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, training and youth pants, swim pants, baby wipes, feminine and incontinence care products, and other related products. The Consumer Tissue segment produces and sells facial and bathroom tissue, paper towels, napkins, and related products for household use. The K-C Professional segment supplies workplace supporting products such as wipers, tissue, towels, apparel, soaps, and sanitizers. The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck in 1872 and is headquartered in Irving, TX.
Company profile
Ticker
KMB
Exchange
CEO
Michael D. Hsu
Employees
Incorporated in
Location
Fiscal year end
Industry (SEC)
SEC CIK
Corporate docs
IRS number
390394230
KMB stock data
()
Calendar
23 Jul 19
14 Oct 19
31 Dec 19
News
Company financial data Financial data
| Quarter (USD) | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|
| Revenue | 4.59B | 4.57B | 4.58B | ||
| Net income | 485M | 454M | 411M | 451M | |
| Diluted EPS | 1.4 | 1.31 | 1.18 | 1.29 | |
| Net profit margin | 10.56% | 9.00% | 9.84% | ||
| Operating income | 670M | 655M | 639M | 669M | |
| Net change in cash | 45M | 10M | |||
| Cash on hand | 534M | 539M | 494M | ||
| Cost of revenue | 3.11B | 3.17B | 3.17B |
| Annual (USD) | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | 18.49B | 18.35B | 18.29B | 18.59B | |
| Net income | 1.41B | 2.28B | 2.17B | 1.01B | |
| Diluted EPS | 4.03 | 6.4 | 5.99 | 2.77 | |
| Net profit margin | 7.63% | 12.42% | 11.84% | 5.45% | |
| Operating income | 2.23B | 3.36B | 3.38B | 1.61B | |
| Net change in cash | -77M | -307M | 304M | -170M | |
| Cash on hand | 539M | 616M | 923M | 619M | |
| Cost of revenue | 12.89B | 11.76B | 11.6B | 11.97B |
Financial data from company earnings reports
Financial report summary
?Competition
Lakeland Industries • Alpha Pro Tech • Black Knight • Sri Surgical Express • Durect • Edgewell Personal Care • Diversey • Diversey • Cellu Tissue • Pacira BiosciencesManagement Discussion
- This section presents a discussion and analysis of our second quarter 2019 net sales, operating profit and other information relevant to an understanding of the results of operations.
- N.M. - Not Meaningful
- (a) "As Adjusted Non-GAAP" may not equal "As Reported" plus "Adjustments" as a result of rounding.
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
audit, Brasil, bringing, da, detail, dispute, exhausted, incentive, judicial, moving, phase, polymer, proposed, reach, Receita, relationship, repayment, resin, review, RFB, Secretaria, significantly, superabsorbent, taxable, ultimately
Removed:
calculate, charge, determine, dividend, face, floating, partially, payment, pricing, promotion, reconciliation, Set, spread, stated
Financial reports
10-Q
2019 Q2
Quarterly report
23 Jul 19
10-Q
2019 Q1
Quarterly report
22 Apr 19
10-K
2018 FY
Annual report
7 Feb 19
10-Q
2018 Q3
Quarterly report
22 Oct 18
10-Q
2018 Q2
Quarterly report
24 Jul 18
10-Q
2018 Q1
Quarterly report
23 Apr 18
10-K
2017 FY
Annual report
8 Feb 18
10-Q
2017 Q3
Quarterly report
23 Oct 17
10-Q
2017 Q2
Quarterly report
25 Jul 17
10-Q
2017 Q1
Quarterly report
24 Apr 17
Current reports
8-K
Kimberly-Clark Names Mark Smucker to Board of Directors
18 Sep 19
8-K
Kimberly-clark Announces Second Quarter 2019 Results
23 Jul 19
8-K
Amendments to Articles of Incorporation or Bylaws
3 May 19
8-K
Other Events
26 Apr 19
8-K
Kimberly-clark Announces First Quarter 2019 Results
22 Apr 19
8-K
Other Events
8 Mar 19
8-K
Departure of Directors or Certain Officers
25 Feb 19
8-K
Departure of Directors or Certain Officers
7 Feb 19
8-K
Kimberly-clark Announces Year-end 2018 Results and 2019 Outlook and Introduces K-C Strategy 2022
23 Jan 19
8-K/A
Departure of Directors or Certain Officers
16 Nov 18
Registration and prospectus
S-8
Registration of securities for employees
24 Sep 19
424B5
Prospectus supplement for primary offering
24 Apr 19
FWP
Free writing prospectus
23 Apr 19
424B5
Prospectus supplement for primary offering
23 Apr 19
S-3ASR
Automatic shelf registration
7 Feb 19
424B5
Prospectus supplement for primary offering
26 Oct 18
FWP
Free writing prospectus
24 Oct 18
424B5
Prospectus supplement for primary offering
24 Oct 18
8-A12B
Registration of securities on exchange
7 Sep 17
424B5
Prospectus supplement for primary offering
1 Sep 17
Proxies
DEFA14A
Additional proxy soliciting materials
8 Mar 19
DEFA14A
Additional proxy soliciting materials
8 Mar 19
DEF 14A
Definitive proxy
8 Mar 19
DEF 14A
Definitive proxy
16 Mar 18
DEFA14A
Additional proxy soliciting materials
16 Mar 18
DEF 14A
Definitive proxy
27 Feb 17
DEFA14A
Additional proxy soliciting materials
27 Feb 17
DEF 14A
Definitive proxy
11 Mar 16
DEFA14A
Additional proxy soliciting materials
11 Mar 16
DEF 14A
Definitive proxy
9 Mar 15
Other
SD
Conflict minerals disclosure
24 May 19
SD
Conflict minerals disclosure
24 May 18
CERTNYS
Certification of approval for NYSE listing
14 Aug 17
SD
Conflict minerals disclosure
24 May 17
SD
Conflict minerals disclosure
27 May 16
NO ACT
No action letter
25 Jan 16
CT ORDER
Confidential treatment order
24 Jul 15
SD
Conflict minerals disclosure
22 May 15
SD
Conflict minerals disclosure
2 Jun 14
NO ACT
No action letter
7 Jan 13